Walgreens 2014 Annual Report Download - page 116

Download and view the complete annual report

Please find page 116 of the 2014 Walgreens annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 120

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120

Exhibit No. Description SEC Document Reference
10.68 Second Amendment to Credit Agreement, dated
as of July 23, 2012, by and among Walgreen
Co., the lenders party thereto, Bank of America,
N.A., as administrative agent and a letter of
credit issuer and Wells Fargo Bank, National
Association, as a letter of credit issuer (including
the Credit Agreement, dated as of July 20, 2011,
as amended by such Second Amendment to
Credit Agreement, as an exhibit thereto).
Incorporated by reference to Exhibit 10.3 to
Walgreen Co.’s Current Report on Form 8-K
(File No. 1-00604) filed with the SEC on
July 26, 2012.
10.69 Shareholders’ Agreement, dated as of August 2,
2012, by and among Alliance Boots GmbH, AB
Acquisition Holdings Limited and Walgreen
Co.
Incorporated by reference to Exhibit 10.1 to
Walgreen Co.’s Current Report on Form 8-K
(File No. 1-00604) filed with the SEC on
August 6, 2012.
10.70 Framework Agreement, dated as of March 18,
2013, by and among Walgreen Co., Alliance
Boots GmbH and AmerisourceBergen
Corporation, including as Annex B-1 thereto, the
form of Warrant 1 and, as Annex B-2 thereto, the
form of Warrant 2 (Walgreen Co. was issued
50% of each of the referenced Warrants).
Incorporated by reference to Exhibit 10.1 to
Walgreen Co.’s Current Report on Form 8-K
(File No. 1-00604) filed with the SEC on
March 20, 2013.
10.71 Shareholders Agreement, dated as of March 18,
2013, by and among Walgreen Co., Alliance
Boots GmbH and AmerisourceBergen
Corporation.
Incorporated by reference to Exhibit 10.2 to
Walgreen Co.’s Current Report on Form 8-K
(File No. 1-00604) filed with the SEC on
March 20, 2013.
10.72 Transaction Rights Agreement, dated as of
March 18, 2013, by and among Walgreen Co.,
Walgreens Pharmacy Strategies, LLC, Alliance
Boots GmbH, Alliance Boots Luxembourg S.à
r.l., and WAB Holdings LLC.
Incorporated by reference to Exhibit 10.3 to
Walgreen Co.’s Current Report on Form 8-K
(File No. 1-00604) filed with the SEC on
March 20, 2013.
10.73 Limited Liability Company Agreement of
WAB Holdings LLC, dated as of March 18,
2013, by and between Walgreens Pharmacy
Strategies, LLC and Alliance Boots
Luxembourg S.à r.l.
Incorporated by reference to Exhibit 99.9 to the
Schedule 13D (File No. 005-77989) filed with
the SEC by Walgreen Co., et. al., with respect
to AmerisourceBergen Corporation common
stock on April 15, 2014.
10.74 Nomination and Support Agreement, dated as
of September 5, 2014, between JANA Partners
LLC and Walgreen Co.
Incorporated by reference to Exhibit 99.1 to
Walgreen Co.’s Current Report on Form 8-K
(File No. 1-00604) filed with the SEC on
September 8, 2014.
12. Computation of Ratio of Earnings to Fixed
Charges.
Previously filed with the Original Form 10-K
on October 20, 2014.
21. Subsidiaries of the Registrant. Previously filed with the Original Form 10-K
on October 20, 2014.
23.1 Consent of Deloitte & Touche LLP. Filed herewith.
23.2 Consent of KPMG LLP. Filed herewith.
23.3 Consent of KPMG LLP. Filed herewith.
108